Hamburg, Germany | Oxford, UK - Evotec OAI AG (Frankfurt Stock Exchange: EVT, TecDAX 30) today announced that the Management Board decided to increase its share capital against contribution in cash from authorised capital, excluding subscription rights of existing shareholders. Sal. Oppenheim as Global Co-ordinator and bookrunner will offer a total of 2.5 million new shares today to institutional investors in Europe by means of an accelerated bookbuilding.
The placement of these shares will support funding the growth of Evotec OAI in its core business, Discovery and Development Services, and will allow the company to potentially engage in a small number of selected additional R&D projects within its Discovery Programs Division.
Due to the capital increase, the number of Evotec OAI shares will rise from 35,510,130 to up to 38,010,130.
Contact:
Evotec OAI AG, Anne Hennecke, Investor Relations, Phone: +49 40 56081 286, Fax: +49 40 56081333, E-mail: investor.relations@evotecoai.com